RootPath
is a biotherapeutics firm that develops and commercializes T cell-based immunotherapies for the treatment of cancer... Read moreRootPath
is a biotherapeutics firm that develops and commercializes T cell-based immunotherapies for the treatment of cancer... Read more
News
Apr 23, 2024
Business Wire
Press Release: RootPath : RootPath Announces Publication Demonstrating How Its Novel Gene Synthesis Technology Empowers Cell Therapy in Solid Tumor Cancers
Nov 21, 2023
Business Wire
Press Release: RootPath : RootPath Announces Its Custom Gene Library, Slashing Gene Synthesis Cost by More Than Half
Nov 09, 2022
Acrofan
RootPath: RootPath Announces Data on Tumor Reactivity Through Its Proprietary Platform at the Society for Immunology of Cancer (SITC) 37th Annual Meeting
May 15, 2022
Acrofan
RootPath: RootPath to Present at the Upcoming American Society of Gene & Cell Therapy Annual Meeting
Apr 06, 2022
Business Wire
Press Release: RootPath : RootPath Announces Presentation and Fireside Chat at Built With Biology 2022
Mar 21, 2022
Business Wire
Press Release: RootPath : RootPath Launches, Elevating Throughput of Gene Function Interrogation by Orders of Magnitude
Jan 09, 2020
BioPortfolio
RootPath: RootPath Raises $11 Million for Personalized TCRCART Solid Tumor Treatments
Sep 01, 2018
ChinaBio Today
RootPath Genomics: Week in Review: Nearly $1 Billion in Cross-Border China Biopharma Deals
Aug 31, 2018
BioPortfolio
RootPath Genomics: RootPath Completes $7 Million Seed Funding for NextGen IO Development
Aug 30, 2018
BioPortfolio
RootPath Genomics: RootPath Raises $7M to Bring Cancer Cell Therapy to Solid Tumors
RootPath Competitors
1
2
3
4
5
6
7
8
9